SBI Securities
IBRX icon

SBI Securities’s ImmunityBio IBRX Stock Holding History

SBI Securities’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.87M Buy
198,491
+62,170
+46% +$497K 0.04% 209
2026
Q2 		$1.19M Sell
136,321
-20,283
-13% -$154K 0.03% 261
2026
Q1 		$1.2M Buy
156,604
+37,282
+31% +$255K 0.03% 243
2025
Q4 		$236K Buy
119,322
+6,016
+5% +$13.6K 0.01% 581
2025
Q3 		$279K Sell
113,306
-4,763
-4% -$12.3K 0.01% 540
2025
Q2 		$312K Buy
118,069
+105,292
+824% +$283K 0.01% 462
2025
Q1 		$38.5K Sell
12,777
-9,900
-44% -$30K ﹤0.01% 1073
2024
Q4 		$58.1K Buy
+22,677
New +$94.5K ﹤0.01% 931

Other funds holding IBRX

Kercheville Advisors
Kercheville Advisors San Antonio, Texas $361M AUM 57.53% 1-Year Est. Return
Sheets Smith Wealth Management
Sheets Smith Wealth Management Winston-Salem, North Carolina $958M AUM 21.88% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Doliver Advisors
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return
MFG Wealth Management
MFG Wealth Management Indianapolis, Indiana $138M AUM 31.54% 1-Year Est. Return
Collective Family Office
Collective Family Office York, Pennsylvania $484M AUM 13.93% 1-Year Est. Return
B. Riley Wealth Advisors
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
Meridian Investment Counsel
Meridian Investment Counsel Lafayette, California $431M AUM 32.55% 1-Year Est. Return
Cherry Creek Investment Advisors
Cherry Creek Investment Advisors Englewood, Colorado $261M AUM 29.65% 1-Year Est. Return

SBI Securities's IBRX Position: Q3 2026 in Review

SBI Securities increased its ImmunityBio (IBRX) stake by 46% in Q3 2026, buying an estimated $497K and bringing the position to 198,491 shares worth $1.87M. The position accounts for 0.04% of the portfolio, ranked #209.

SBI Securities first reported a position in IBRX in Q4 2024 and has held it in 8 quarters since. 70 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • SBI Securities held 198,491 shares of ImmunityBio worth $1.87M as of Q3 2026.
  • SBI Securities bought 62,170 ImmunityBio shares in Q3 2026, an estimated $497K.
  • ImmunityBio made up 0.04% of SBI Securities's portfolio in Q3 2026, its #209 holding.
  • SBI Securities first reported a position in ImmunityBio in Q4 2024 and has held it in 8 quarters since.
  • 70 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.